-
- Erratum in:
- N Engl J Med 1999 Nov 4;341(19):1484.
- Comment in:
-
N Engl J Med. 2000 Feb 3;342(5):358-9.
Acute myeloid leukemia.
Department of Hematology, Erasmus University and University Hospital Rotterdam, The Netherlands.
PMID: 10502596 [PubMed - indexed for MEDLINE]
-
Cited by 19 PubMed Central articles
-
The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia.
Lee SR, Yang DH, Ahn JS, Kim YK, Lee JJ, Choi YJ, Shin HJ, Chung JS, Cho YY, Chae YS, et al.
J Korean Med Sci. 2009 Jun; 24(3):498-503. Epub 2009 Jun 15.
[J Korean Med Sci. 2009]
-
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, Chen P, Wang Y, Yan M, Qian Z, et al.
Proc Natl Acad Sci U S A. 2008 Oct 7; 105(40):15535-40. Epub 2008 Oct 1.
[Proc Natl Acad Sci U S A. 2008]
-
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.
Sierra J, Szer J, Kassis J, Herrmann R, Lazzarino M, Thomas X, Noga SJ, Baker N, Dansey R, Bosi A.
BMC Cancer. 2008 Jul 10; 8:195. Epub 2008 Jul 10.
[BMC Cancer. 2008]
- » See all...